loadpatents
name:-0.014452934265137
name:-0.01226806640625
name:-0.0066590309143066
Park; Yoonkyung Patent Filings

Park; Yoonkyung

Patent Applications and Registrations

Patent applications and USPTO patent grants for Park; Yoonkyung.The latest application filed is for "novel antimicrobial peptide derived from pseudin-2 peptide and uses thereof".

Company Profile
7.12.13
  • Park; Yoonkyung - Jeollanam-do KR
  • Park; Yoonkyung - Gwangju KR
  • Park; Yoonkyung - Seoul KR
  • Park; Yoonkyung - Nam-myeon KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antimicrobial peptide derived from LL37 peptide and uses thereof
Grant 11,452,758 - Park , et al. September 27, 2
2022-09-27
Novel Antimicrobial Peptide Derived From Pseudin-2 Peptide And Uses Thereof
App 20220153789 - PARK; Yoonkyung ;   et al.
2022-05-19
Antimicrobial peptide derived from Hp1404 peptide and uses thereof
Grant 11,117,931 - Park , et al. September 14, 2
2021-09-14
Antimicrobial peptide from skate skin and uses thereof
Grant 11,077,170 - Park , et al. August 3, 2
2021-08-03
Novel Antimicrobial Peptide Derived From Ll37 Peptide And Uses Thereof
App 20210052696 - PARK; Yoonkyung ;   et al.
2021-02-25
Antimicrobial peptide derived from myxinidin peptide and uses thereof
Grant 10,919,935 - Park , et al. February 16, 2
2021-02-16
Novel Antimicrobial Peptide From Skate Skin And Uses Thereof
App 20200254057 - Kind Code
2020-08-13
Novel Antimicrobial Peptide Derived From Myxinidin Peptide And Uses Thereof
App 20200231628 - PARK; Yoonkyung ;   et al.
2020-07-23
NOVEL ANTIMICROBIAL PEPTIDE DERIVED FROM Hp1404 PEPTIDE AND USES THEREOF
App 20200216497 - PARK; Yoonkyung ;   et al.
2020-07-09
Three-dimensional (3D) display device
Grant 10,495,891 - Kim , et al. De
2019-12-03
Anti-inflammatory Composition Comprising Clavaspirin Peptide Analogue As Effective Ingredient
App 20190038714 - PARK; Yoonkyung ;   et al.
2019-02-07
Analogue peptide CMA3 derived from CM-MA peptide and use thereof
Grant 9,862,749 - Park January 9, 2
2018-01-09
Display device
Grant 9,664,958 - Seo , et al. May 30, 2
2017-05-30
Three-dimensional (3d) Display Device
App 20170139221 - KIM; IL-JOO ;   et al.
2017-05-18
Three-dimensional (3D) display device
Grant 9,581,824 - Kim , et al. February 28, 2
2017-02-28
Analogue Peptide CMA3 Derived from CM-MA Peptide and Use Thereof
App 20160326218 - PARK; Yoonkyung
2016-11-10
Methods of use for an antimicrobial peptide
Grant 9,278,121 - Song , et al. March 8, 2
2016-03-08
Three-dimensional (3d) Display Device
App 20150253579 - KIM; IL-JOO ;   et al.
2015-09-10
Display Device
App 20150205162 - SEO; Hyunseung ;   et al.
2015-07-23
Methods Of Use For An Antimicrobial Peptide
App 20140274879 - Song; Peter I. ;   et al.
2014-09-18
Antibiotic peptide derived from ribosomal protein L1 of Helicobacter pylori and use thereof
Grant 8,410,046 - Hahm , et al. April 2, 2
2013-04-02
Novel Antibiotic Peptide Derived From Ribosomal Protein L1 Of Helicobacter Pylori And Use Thereof
App 20110053834 - Hahm; Kyung-Soo ;   et al.
2011-03-03
Peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof
Grant 6,800,727 - Hahm , et al. October 5, 2
2004-10-05
Novel peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof
App 20030096745 - Hahm, Kyung-Soo ;   et al.
2003-05-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed